![](/img/cover-not-exists.png)
Phase I/II study exploring ImMucin, a pan-major histocompatibility complex, anti-MUC1 signal peptide vaccine, in multiple myeloma patients
Carmon, Lior, Avivi, Irit, Kovjazin, Riva, Zuckerman, Tsila, Dray, Lillian, Gatt, Moshe E., Or, Reuven, Shapira, Michael Y.Volume:
169
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.13245
Date:
April, 2015
File:
PDF, 763 KB
english, 2015